Technical Analysis for TRVI - Trevi Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 5.82 6.40% 0.35
TRVI closed up 6.4 percent on Friday, July 10, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down
Historical TRVI trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 6.40%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 6.40%
NR7 Range Contraction 6.40%
NR7-2 Range Contraction 6.40%
Doji - Bullish? Reversal 6.40%
Stochastic Reached Oversold Weakness 6.40%
Wide Bands Range Expansion 6.40%
Oversold Stochastic Weakness 6.40%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Trevi is currently conducting a Phase 2b/3 clinical trial of nalbuphine ER, referred to as the PRISM trial, in patients with severe pruritus associated with prurigo nodularis. Founded in 2011, Trevi Therapeutics is headquartered in New Haven, CT.
Biopharmaceutical Organ Systems Chemical Compounds Organic Compounds Analgesics Morphinans Idiopathic Pulmonary Fibrosis Ethers Phenols Parkinson’s Disease Chronic Cough Levodopa Induced Dyskinesia Prurigo

Is TRVI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.49
52 Week Low 1.33
Average Volume 98,820
200-Day Moving Average 4.03
50-Day Moving Average 4.20
20-Day Moving Average 5.85
10-Day Moving Average 6.33
Average True Range 0.94
ADX 51.13
+DI 21.98
-DI 13.94
Chandelier Exit (Long, 3 ATRs ) 5.66
Chandelier Exit (Short, 3 ATRs ) 6.53
Upper Bollinger Band 7.36
Lower Bollinger Band 4.34
Percent B (%b) 0.49
BandWidth 51.69
MACD Line 0.52
MACD Signal Line 0.68
MACD Histogram -0.1647
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.11
Resistance 3 (R3) 7.05 6.55 6.89
Resistance 2 (R2) 6.55 6.22 6.58 6.82
Resistance 1 (R1) 6.19 6.02 6.37 6.25 6.75
Pivot Point 5.69 5.69 5.79 5.73 5.69
Support 1 (S1) 5.33 5.36 5.51 5.39 4.89
Support 2 (S2) 4.83 5.16 4.87 4.82
Support 3 (S3) 4.47 4.83 4.75
Support 4 (S4) 4.53